Analysis of central and peripheral pth decay values in patients with primary hyperparathyroidism
Introduction: Parathyroidectomy is the only curative approach for primary hyperparathyroidism (HPTP). Several techniques are studied for a more targeted surgery. One of them consists of intraoperative PTH measurement (IO-PTH), which can be collected from a Peripheral Vein (PV) or from a Central Vein (CV), using the Internal Jugular Vein (VJI). Objective: The aim of this study was to analyze the peculiarities of the collection sites. Methods: It is a prospective study of patients undergoing parathyroidectomy by HPTP, with PTH values in the peripheral collection and from the ipsilateral VJI at times: initial (T0) and 10 minutes after removal of the diseased gland (T10). Results: 61 participants were evaluated. The median PTH at baseline was 147.9 in the peripheral vein and 476.58 in the central vein. The median at T10 was 36 in the peripheral vein and 33 in the central vein. The central vein values showed a greater reduction, with the peripheral values showing a median decay of 74.35%, while the central values dropped by 82.38%. In the initial collection, PTH values were higher in the central vein, while they tended towards homeostasis after the removal of the diseased gland, regardless of the collection site. Thus, the average decay values from the central vein collections were higher and more significant than those from the peripheral veins. Conclusion: The use of central values thus implies greater reliability for to intraoperative monitoring, with long-term comparative studies still being necessary to determine more targeted and effective surgical approaches
1. Ito F, Sippel R, Lederman J, Chen H. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg. 2007;245(6):959-63. http://dx.doi.org/10.1097/01.sla.0000255578.11198.ff. PMid:17522522.
2. Khan ZF, Lew JI. Intraoperative parathyroid hormone monitoring in the surgical management of sporadic primary hyperparathyroidism. Endocrinol Metab. 2019;34(4):327-39. http://dx.doi.org/10.3803/EnM.2019.34.4.327. PMid:31884732.
3. Woodrum DT, Saunders BD, England BG, Burney RE, Doherty GM, Gauger PG. The influence of sample site on intraoperative PTH monitoring during parathyroidectomy. Surgery. 2004;136(6):1169-75. http://dx.doi.org/10.1016/j.surg.2004.06.043. PMid:15657572.
4. Neves MC, Ohe MN, Rosano M, Abrahão M, Cervantes O, Lazaretti-Castro M, Vieira JG, Kunii IS, Santos RO. A 10-year experience in intraoperative parathyroid hormone measurements for primary hyperparathyroidism: a prospective study of 91 previous unexplored patients. J Osteoporos. 2012;2012:914214. http://dx.doi.org/10.1155/2012/914214. PMid:22523718.
5. Ribeiro D, Lera M, Fonseca A, Neves M. Analysis of PTH serum concentration from internal jugular veins of patients with primary hyperparathyroidism. Archives of Head and Neck Surgery. 2019;48(2):e00222019. http://dx.doi.org/10.4322/ahns.2019.0011.
6. Barczynski M, Konturek A, Cichon S, Hubalewska-Dydejczyk A, Golkowski F, Huszno B. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol. 2007;66(6):878-85. http://dx.doi.org/10.1111/j.1365-2265.2007.02827.x. PMid:17437518.
7. Stalberg P, Sidhu S, Sywak M, Robinson B, Wilkinson M, Delbridge L. Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy:
does it “value-add” to decision-making? J Am Coll Surg. 2006;203(1):1-6. http://dx.doi.org/10.1016/j.jamcollsurg.2006.03.022. PMid:16798481.
8. Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138(4):583-90. http://dx.doi.org/10.1016/j.surg.2005.06.046.PMid:16269285.
9. Jacobson SR, Van Heerden JA, Farley DR, Grant CS, Thompson GB, Mullan BP, Curlee KJ. Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe. World J Surg. 2004;28(11):1127-31. http://dx.doi.org/10.1007/s00268-004-7469-2. PMid:15490069.]
10. Foley CS, Moore EC, Milas M, Berber E, Shin J, Siperstein AE. Receiver operating characteristic analysis of intraoperative parathyroid hormone monitoring to determine optimum sensitivity and specificity: analysis of 896 cases. Endocr Pract. 2019;25(11):1117-26. http://dx.doi.org/10.4158/EP-2019-0191. PMid:31414903.
11. Freitas LCC, Mamede RCM. Dinâmica da secreção de paratormônio após paratireoidectomia total e autotransplante [thesis]. Ribeirão Preto: Universidade de São Paulo, 2007.